{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:41:38Z","timestamp":1793878898967,"version":"4.7.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"8085","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2025,10,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Neuroblastoma is a highly lethal childhood tumour derived from differentiation-arrested neural crest cells\n                    <jats:sup>1,2<\/jats:sup>\n                    . Like all cancers, its growth is fuelled by metabolites obtained from either circulation or local biosynthesis\n                    <jats:sup>3,4<\/jats:sup>\n                    . Neuroblastomas depend on local polyamine biosynthesis, and the inhibitor difluoromethylornithine has\u00a0shown clinical activity\n                    <jats:sup>5<\/jats:sup>\n                    . Here we show that such inhibition can be augmented by dietary restriction of upstream amino acid substrates, leading to disruption of oncogenic protein translation, tumour differentiation and profound survival gains in the\n                    <jats:italic>Th-MYCN<\/jats:italic>\n                    mouse model. Specifically, an arginine- and proline-free diet decreases the amount of the polyamine precursor ornithine and enhances tumour polyamine depletion by difluoromethylornithine. This polyamine depletion causes ribosome stalling, unexpectedly specifically at codons with adenosine in the third position. Such codons are selectively enriched in cell cycle genes and low in neuronal differentiation genes. Thus, impaired translation of these codons, induced by combined dietary and pharmacological intervention, favours a pro-differentiation proteome. These results suggest that the genes of specific cellular programmes have evolved hallmark codon usage preferences that enable coherent translational rewiring in response to metabolic stresses, and that this process can be targeted to activate differentiation of paediatric cancers.\n                  <\/jats:p>","DOI":"10.1038\/s41586-025-09564-0","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T15:02:18Z","timestamp":1758726138000},"page":"707-715","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Reprogramming neuroblastoma by diet-enhanced polyamine depletion"],"prefix":"10.1038","volume":"646","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0636-4177","authenticated-orcid":false,"given":"Sarah","family":"Cherkaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3962-6740","authenticated-orcid":false,"given":"Christina S.","family":"Turn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1787-2617","authenticated-orcid":false,"given":"Wenyun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Eigenmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olesya O.","family":"Panasenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Om H.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6944-2232","authenticated-orcid":false,"given":"Lea F.","family":"Surrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra D.","family":"Kienast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian A.","family":"Leidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wierer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2961-3065","authenticated-orcid":false,"given":"Eileen","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1247-4727","authenticated-orcid":false,"given":"Joshua D.","family":"Rabinowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9221-4852","authenticated-orcid":false,"given":"Michael D.","family":"Hogarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3378-9266","authenticated-orcid":false,"given":"Raphael J.","family":"Morscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"9564_CR1","doi-asserted-by":"publisher","first-page":"16078","DOI":"10.1038\/nrdp.2016.78","volume":"2","author":"KK Matthay","year":"2016","unstructured":"Matthay, K. K. et al. Neuroblastoma. Nat. Rev. Dis. Primers 2, 16078 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"9564_CR2","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1200\/JCO.2014.59.4648","volume":"33","author":"NR Pinto","year":"2015","unstructured":"Pinto, N. R. et al. Advances in risk classification and treatment strategies for neuroblastoma. J. Clin. Oncol. 33, 3008\u20133017 (2015).","journal-title":"J. Clin. Oncol."},{"key":"9564_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","volume":"3","author":"I Elia","year":"2021","unstructured":"Elia, I. & Haigis, M. C. Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism. Nat. Metab. 3, 21\u201332 (2021).","journal-title":"Nat. Metab."},{"key":"9564_CR4","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis, R. J. & Chandel, N. S. Fundamentals of cancer metabolism. Sci. Adv. 2, e1600200 (2016).","journal-title":"Sci. Adv."},{"key":"9564_CR5","doi-asserted-by":"crossref","unstructured":"Oesterheld, J. et al. Eflornithine as postimmunotherapy maintenance in high-risk neuroblastoma: externally controlled, propensity score-matched survival outcome comparisons. J. Clin. Oncol. 42, 90\u2013102 (2024).","DOI":"10.1200\/JCO.22.02875"},{"key":"9564_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/305245a0","volume":"305","author":"M Schwab","year":"1983","unstructured":"Schwab, M. et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305, 245\u2013248 (1983).","journal-title":"Nature"},{"key":"9564_CR7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1126\/science.6719137","volume":"224","author":"GM Brodeur","year":"1984","unstructured":"Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E. & Bishop, J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224, 1121\u20131124 (1984).","journal-title":"Science"},{"key":"9564_CR8","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJM198510313131802","volume":"313","author":"RC Seeger","year":"1985","unstructured":"Seeger, R. C. et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med. 313, 1111\u20131116 (1985).","journal-title":"N. Engl. J. Med."},{"key":"9564_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1200\/JCO.2007.13.8925","volume":"27","author":"KK Matthay","year":"2009","unstructured":"Matthay, K. K. et al. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children\u2019s oncology group study. J. Clin. Oncol. 27, 1007\u20131013 (2009).","journal-title":"J. Clin. Oncol."},{"key":"9564_CR10","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1093\/emboj\/16.11.2985","volume":"16","author":"WA Weiss","year":"1997","unstructured":"Weiss, W. A., Aldape, K., Mohapatra, G., Feuerstein, B. G. & Bishop, J. M. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J. 16, 2985\u20132995 (1997).","journal-title":"EMBO J."},{"key":"9564_CR11","doi-asserted-by":"publisher","first-page":"7804","DOI":"10.1073\/pnas.90.16.7804","volume":"90","author":"C Bello-Fernandez","year":"1993","unstructured":"Bello-Fernandez, C., Packham, G. & Cleveland, J. L. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl Acad. Sci. USA 90, 7804\u20137808 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9564_CR12","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/jpm11121286","volume":"11","author":"B Decaesteker","year":"2021","unstructured":"Decaesteker, B. et al. From DNA copy number gains and tumor dependencies to novel therapeutic targets for high-risk neuroblastoma. J. Pers. Med. 11, 1286 (2021).","journal-title":"J. Pers. Med."},{"key":"9564_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/jn\/115.4.509","volume":"115","author":"ME Jones","year":"1985","unstructured":"Jones, M. E. Conversion of glutamate to ornithine and proline: pyrroline-5-carboxylate, a possible modulator of arginine requirements. J. Nutr. 115, 509\u2013515 (1985).","journal-title":"J. Nutr."},{"key":"9564_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/biology6010018","volume":"6","author":"A Ginguay","year":"2017","unstructured":"Ginguay, A., Cynober, L., Curis, E. & Nicolis, I. Ornithine aminotransferase, an important glutamate-metabolizing enzyme at the crossroads of multiple metabolic pathways. Biology 6, 18 (2017).","journal-title":"Biology"},{"key":"9564_CR15","first-page":"95","volume":"6","author":"MGM de Sain-van der Velden","year":"2012","unstructured":"de Sain-van der Velden, M. G. M. et al. The proline\/citrulline ratio as a biomarker for OAT deficiency in early infancy. JIMD Rep. 6, 95\u201399 (2012).","journal-title":"JIMD Rep."},{"key":"9564_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41586-023-05891-2","volume":"616","author":"MS Lee","year":"2023","unstructured":"Lee, M. S. et al. Ornithine aminotransferase supports polyamine synthesis in pancreatic cancer. Nature 616, 339\u2013347 (2023).","journal-title":"Nature"},{"key":"9564_CR17","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41586-024-08146-w","volume":"635","author":"KW Ryu","year":"2024","unstructured":"Ryu, K. W. et al. Cellular ATP demand creates metabolically distinct subpopulations of mitochondria. Nature 635, 746\u2013754 (2024).","journal-title":"Nature"},{"key":"9564_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature24057","volume":"551","author":"S Hui","year":"2017","unstructured":"Hui, S. et al. Glucose feeds the TCA cycle via circulating lactate. Nature 551, 115\u2013118 (2017).","journal-title":"Nature"},{"key":"9564_CR19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41568-023-00632-z","volume":"23","author":"CR Bartman","year":"2023","unstructured":"Bartman, C. R., Faubert, B., Rabinowitz, J. D. & DeBerardinis, R. J. Metabolic pathway analysis using stable isotopes in patients with cancer. Nat. Rev. Cancer 23, 863\u2013878 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"9564_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2016.01.007","volume":"23","author":"SM Davidson","year":"2016","unstructured":"Davidson, S. M. et al. Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer. Cell Metab. 23, 517\u2013528 (2016).","journal-title":"Cell Metab."},{"key":"9564_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1203\/PDR.0b013e3181fc6ab7","volume":"69","author":"C Tomlinson","year":"2011","unstructured":"Tomlinson, C., Rafii, M., Sgro, M., Ball, R. O. & Pencharz, P. Arginine is synthesized from proline, not glutamate, in enterally fed human preterm neonates. Pediatr. Res. 69, 46\u201350 (2011).","journal-title":"Pediatr. Res."},{"key":"9564_CR22","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3945\/jn.110.137224","volume":"141","author":"C Tomlinson","year":"2011","unstructured":"Tomlinson, C., Rafii, M., Ball, R. O. & Pencharz, P. B. Arginine can be synthesized from enteral proline in healthy adult humans. J. Nutr. 141, 1432\u20131436 (2011).","journal-title":"J. Nutr."},{"key":"9564_CR23","doi-asserted-by":"publisher","first-page":"9735","DOI":"10.1158\/0008-5472.CAN-07-6866","volume":"68","author":"MD Hogarty","year":"2008","unstructured":"Hogarty, M. D. et al. ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma. Cancer Res. 68, 9735\u20139745 (2008).","journal-title":"Cancer Res."},{"key":"9564_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau1099","volume":"11","author":"LD Gamble","year":"2019","unstructured":"Gamble, L. D. et al. Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma. Sci. Transl. Med. 11, eaau1099 (2019).","journal-title":"Sci. Transl. Med."},{"key":"9564_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1158\/0008-5472.CAN-08-2968","volume":"69","author":"RJ Rounbehler","year":"2009","unstructured":"Rounbehler, R. J. et al. Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma. Cancer Res. 69, 547\u2013553 (2009).","journal-title":"Cancer Res."},{"key":"9564_CR26","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1073\/pnas.60.4.1420","volume":"60","author":"D Russell","year":"1968","unstructured":"Russell, D. & Snyder, S. H. Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc. Natl Acad. Sci. USA 60, 1420\u20131427 (1968).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9564_CR27","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1073\/pnas.78.5.2869","volume":"78","author":"MH Park","year":"1981","unstructured":"Park, M. H., Cooper, H. L. & Folk, J. E. Identification of hypusine, an unusual amino acid, in a protein from human lymphocytes and of spermidine as its biosynthetic precursor. Proc. Natl Acad. Sci. USA 78, 2869\u20132873 (1981).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9564_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.molcel.2017.03.003","volume":"66","author":"AP Schuller","year":"2017","unstructured":"Schuller, A. P., Wu, C. C., Dever, T. E., Buskirk, A. R. & Green, R. eIF5A functions globally in translation elongation and termination. Mol. Cell 66, 194\u2013205.e5 (2017).","journal-title":"Mol. Cell"},{"key":"9564_CR29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1158\/2643-3230.BCD-22-0162","volume":"4","author":"S Nakanishi","year":"2023","unstructured":"Nakanishi, S. et al. The polyamine\u2013hypusine circuit controls an oncogenic translational program essential for malignant conversion in MYC-driven lymphoma. Blood Cancer Discov. 4, 294\u2013317 (2023).","journal-title":"Blood Cancer Discov."},{"key":"9564_CR30","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cmet.2019.05.003","volume":"30","author":"DJ Puleston","year":"2019","unstructured":"Puleston, D. J. et al. Polyamines and eIF5A hypusination modulate mitochondrial respiration and macrophage activation. Cell Metab. 30, 352\u2013363.e8 (2019).","journal-title":"Cell Metab."},{"key":"9564_CR31","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1016\/j.cell.2021.06.007","volume":"184","author":"DJ Puleston","year":"2021","unstructured":"Puleston, D. J. et al. Polyamine metabolism is a central determinant of helper T cell lineage fidelity. Cell 184, 4186\u20134202.e20 (2021).","journal-title":"Cell"},{"key":"9564_CR32","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41580-018-0011-4","volume":"19","author":"AP Schuller","year":"2018","unstructured":"Schuller, A. P. & Green, R. Roadblocks and resolutions in eukaryotic translation. Nat. Rev. Mol. Cell Biol. 19, 526\u2013541 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"9564_CR33","doi-asserted-by":"publisher","first-page":"11275","DOI":"10.1093\/nar\/gku837","volume":"42","author":"HL Lightfoot","year":"2014","unstructured":"Lightfoot, H. L. & Hall, J. Endogenous polyamine function\u2014the RNA perspective. Nucleic Acids Res. 42, 11275\u201311290 (2014).","journal-title":"Nucleic Acids Res."},{"key":"9564_CR34","doi-asserted-by":"publisher","first-page":"167073","DOI":"10.1016\/j.jmb.2021.167073","volume":"433","author":"KS Winther","year":"2021","unstructured":"Winther, K. S., S\u00f8rensen, M. A. & Svenningsen, S. L. Polyamines are required for tRNA Anticodon modification in Escherichia coli. J. Mol. Biol. 433, 167073 (2021).","journal-title":"J. Mol. Biol."},{"key":"9564_CR35","doi-asserted-by":"publisher","first-page":"18719","DOI":"10.1074\/jbc.TM118.003338","volume":"293","author":"TE Dever","year":"2018","unstructured":"Dever, T. E. & Ivanov, I. P. Roles of polyamines in translation. J. Biol. Chem. 293, 18719\u201318729 (2018).","journal-title":"J. Biol. Chem."},{"key":"9564_CR36","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cell.2014.08.011","volume":"158","author":"H Gingold","year":"2014","unstructured":"Gingold, H. et al. A dual program for translation regulation in cellular proliferation and differentiation. Cell 158, 1281\u20131292 (2014).","journal-title":"Cell"},{"key":"9564_CR37","doi-asserted-by":"publisher","first-page":"216120","DOI":"10.1016\/j.canlet.2023.216120","volume":"559","author":"S Coni","year":"2023","unstructured":"Coni, S. et al. Combined inhibition of polyamine metabolism and eIF5A hypusination suppresses colorectal cancer growth through a converging effect on MYC translation. Cancer Lett. 559, 216120 (2023).","journal-title":"Cancer Lett."},{"key":"9564_CR38","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/ng.3921","volume":"49","author":"V Boeva","year":"2017","unstructured":"Boeva, V. et al. Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries. Nat. Genet. 49, 1408\u20131413 (2017).","journal-title":"Nat. Genet."},{"key":"9564_CR39","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/ng.3899","volume":"49","author":"T van Groningen","year":"2017","unstructured":"van Groningen, T. et al. Neuroblastoma is composed of two super-enhancer-associated differentiation states. Nat. Genet. 49, 1261\u20131266 (2017).","journal-title":"Nat. Genet."},{"key":"9564_CR40","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/s41588-018-0191-z","volume":"50","author":"AD Durbin","year":"2018","unstructured":"Durbin, A. D. et al. Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry. Nat. Genet. 50, 1240\u20131246 (2018).","journal-title":"Nat. Genet."},{"key":"9564_CR41","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/sj.onc.1201263","volume":"15","author":"D Sakamuro","year":"1997","unstructured":"Sakamuro, D., Sabbatini, P., White, E. & Prendergast, G. C. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15, 887\u2013898 (1997).","journal-title":"Oncogene"},{"key":"9564_CR42","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ccell.2020.04.005","volume":"37","author":"M Tajan","year":"2020","unstructured":"Tajan, M. & Vousden, K. H. Dietary approaches to cancer therapy. Cancer Cell 37, 767\u2013785 (2020).","journal-title":"Cancer Cell"},{"key":"9564_CR43","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41568-022-00485-y","volume":"22","author":"SR Taylor","year":"2022","unstructured":"Taylor, S. R., Falcone, J. N., Cantley, L. C. & Goncalves, M. D. Developing dietary interventions as therapy for cancer. Nat. Rev. Cancer 22, 452\u2013466 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"9564_CR44","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41586-018-0343-4","volume":"560","author":"BD Hopkins","year":"2018","unstructured":"Hopkins, B. D. et al. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature 560, 499\u2013503 (2018).","journal-title":"Nature"},{"key":"9564_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.medj.2021.12.008","volume":"3","author":"L Yang","year":"2022","unstructured":"Yang, L. et al. Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth. Med 3, 119\u2013136 (2022).","journal-title":"Med"},{"key":"9564_CR46","doi-asserted-by":"publisher","first-page":"17060","DOI":"10.18632\/oncotarget.7929","volume":"7","author":"RJ Morscher","year":"2016","unstructured":"Morscher, R. J. et al. Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model. Oncotarget 7, 17060\u201317073 (2016).","journal-title":"Oncotarget"},{"key":"9564_CR47","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature22056","volume":"544","author":"ODK Maddocks","year":"2017","unstructured":"Maddocks, O. D. K. et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature 544, 372\u2013376 (2017).","journal-title":"Nature"},{"key":"9564_CR48","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41586-021-04244-1","volume":"601","author":"P Thandapani","year":"2022","unstructured":"Thandapani, P. et al. Valine tRNA levels and availability regulate complex I assembly in leukaemia. Nature 601, 428\u2013433 (2022).","journal-title":"Nature"},{"key":"9564_CR49","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/cncr.25489","volume":"117","author":"R Pieters","year":"2011","unstructured":"Pieters, R. et al. l\u2010Asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase. Cancer 117, 238\u2013249 (2011).","journal-title":"Cancer"},{"key":"9564_CR50","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1158\/0008-5472.CAN-18-2139","volume":"79","author":"L Fultang","year":"2019","unstructured":"Fultang, L. et al. Macrophage-derived IL1\u03b2 and TNF\u03b1 regulate arginine metabolism in neuroblastoma. Cancer Res. 79, 611\u2013624 (2019).","journal-title":"Cancer Res."},{"key":"9564_CR51","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41586-024-07840-z","volume":"633","author":"S Imada","year":"2024","unstructured":"Imada, S. et al. Short-term post-fast refeeding enhances intestinal stemness via polyamines. Nature 633, 895\u2013904 (2024).","journal-title":"Nature"},{"key":"9564_CR52","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41591-019-0383-9","volume":"25","author":"M Filbin","year":"2019","unstructured":"Filbin, M. & Monje, M. Developmental origins and emerging therapeutic opportunities for childhood cancer. Nat. Med. 25, 367\u2013376 (2019).","journal-title":"Nat. Med."},{"key":"9564_CR53","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41591-023-02221-x","volume":"29","author":"F Comitani","year":"2023","unstructured":"Comitani, F. et al. Diagnostic classification of childhood cancer using multiscale transcriptomics. Nat. Med. 29, 656\u2013666 (2023).","journal-title":"Nat. Med."},{"key":"9564_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36735-2","volume":"14","author":"B Decaesteker","year":"2023","unstructured":"Decaesteker, B. et al. SOX11 regulates SWI\/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry. Nat. Commun. 14, 1267 (2023).","journal-title":"Nat. Commun."},{"key":"9564_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang, C. V. MYC on the path to cancer. Cell 149, 22\u201335 (2012).","journal-title":"Cell"},{"key":"9564_CR56","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1056\/NEJM199910143411601","volume":"341","author":"KK Matthay","year":"1999","unstructured":"Matthay, K. K. et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. N. Engl. J. Med. 341, 1165\u20131173 (1999).","journal-title":"N. Engl. J. Med."},{"key":"9564_CR57","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0304-3835(03)00108-3","volume":"197","author":"CP Reynolds","year":"2003","unstructured":"Reynolds, C. P., Matthay, K. K., Villablanca, J. G. & Maurer, B. J. Retinoid therapy of high-risk neuroblastoma. Cancer Lett. 197, 185\u2013192 (2003).","journal-title":"Cancer Lett."},{"key":"9564_CR58","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1023\/B:CLIN.0000046176.33867.c5","volume":"21","author":"M McLean","year":"2004","unstructured":"McLean, M. et al. A BALB\/c murine lung alveolar carcinoma used to establish a surgical spontaneous metastasis model. Clin. Exp. Metastasis 21, 363\u2013369 (2004).","journal-title":"Clin. Exp. Metastasis"},{"key":"9564_CR59","first-page":"5266","volume":"63","author":"CS Hackett","year":"2003","unstructured":"Hackett, C. S. et al. Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors. Cancer Res. 63, 5266\u20135273 (2003).","journal-title":"Cancer Res."},{"key":"9564_CR60","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1136\/jcp.2007.054627","volume":"61","author":"HC Moore","year":"2008","unstructured":"Moore, H. C. et al. Histological profile of tumours from MYCN transgenic mice. J. Clin. Pathol. 61, 1098\u20131103 (2008).","journal-title":"J. Clin. Pathol."},{"key":"9564_CR61","doi-asserted-by":"publisher","first-page":"12664","DOI":"10.1073\/pnas.0401083101","volume":"101","author":"LM Hansford","year":"2004","unstructured":"Hansford, L. M. et al. Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification. Proc. Natl Acad. Sci. USA 101, 12664\u201312669 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9564_CR62","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1021\/ac902837x","volume":"82","author":"W Lu","year":"2010","unstructured":"Lu, W. et al. Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometer. Anal. Chem. 82, 3212\u20133221 (2010).","journal-title":"Anal. Chem."},{"key":"9564_CR63","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/mmi.13006","volume":"96","author":"Y Yang","year":"2015","unstructured":"Yang, Y. et al. Relation between chemotaxis and consumption of amino acids in bacteria. Mol. Microbiol. 96, 1272\u20131282 (2015).","journal-title":"Mol. Microbiol."},{"key":"9564_CR64","doi-asserted-by":"publisher","first-page":"e11033","DOI":"10.15252\/msb.202211033","volume":"18","author":"S Cherkaoui","year":"2022","unstructured":"Cherkaoui, S. et al. A functional analysis of 180 cancer cell lines reveals conserved intrinsic metabolic programs. Mol. Syst. Biol. 18, e11033 (2022).","journal-title":"Mol. Syst. Biol."},{"key":"9564_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.84","volume":"4","author":"H Kocak","year":"2013","unstructured":"Kocak, H. et al. Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma. Cell Death Dis. 4, e586 (2013).","journal-title":"Cell Death Dis."},{"key":"9564_CR66","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"9564_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2017.183","volume":"4","author":"JL Harenza","year":"2017","unstructured":"Harenza, J. L. et al. Corrigendum: transcriptomic profiling of 39 commonly-used neuroblastoma cell lines. Sci. Data 4, 170183 (2017).","journal-title":"Sci. Data"},{"key":"9564_CR68","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi, M. et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature 569, 503\u2013508 (2019).","journal-title":"Nature"},{"key":"9564_CR69","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1126\/science.1168978","volume":"324","author":"NT Ingolia","year":"2009","unstructured":"Ingolia, N. T., Ghaemmaghami, S., Newman, J. R. & Weissman, J. S. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 324, 218\u2013223 (2009).","journal-title":"Science"},{"key":"9564_CR70","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ymeth.2017.05.028","volume":"126","author":"NJ McGlincy","year":"2017","unstructured":"McGlincy, N. J. & Ingolia, N. T. Transcriptome-wide measurement of translation by ribosome profiling. Methods 126, 112\u2013129 (2017).","journal-title":"Methods"},{"key":"9564_CR71","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357\u2013360 (2015).","journal-title":"Nat. Methods"},{"key":"9564_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"9564_CR73","doi-asserted-by":"publisher","first-page":"e1006169","DOI":"10.1371\/journal.pcbi.1006169","volume":"14","author":"F Lauria","year":"2018","unstructured":"Lauria, F. et al. riboWaltz: optimization of ribosome P-site positioning in ribosome profiling data. PLoS Comput. Biol. 14, e1006169 (2018).","journal-title":"PLoS Comput. Biol."},{"key":"9564_CR74","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.15252\/embr.201540717","volume":"16","author":"R Elkon","year":"2015","unstructured":"Elkon, R. et al. Myc coordinates transcription and translation to enhance transformation and suppress invasiveness. EMBO Rep. 16, 1723\u20131736 (2015).","journal-title":"EMBO Rep."},{"key":"9564_CR75","doi-asserted-by":"publisher","first-page":"114134","DOI":"10.1016\/j.celrep.2024.114134","volume":"43","author":"MP Volegova","year":"2024","unstructured":"Volegova, M. P. et al. The MYCN 5\u2032 UTR as a therapeutic target in neuroblastoma. Cell Rep. 43, 114134 (2024).","journal-title":"Cell Rep."},{"key":"9564_CR76","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s13361-018-1999-6","volume":"29","author":"M Jora","year":"2018","unstructured":"Jora, M. et al. Differentiating positional isomers of nucleoside modifications by higher-energy collisional dissociation mass spectrometry (HCD MS). J. Am. Soc. Mass Spectrom. 29, 1745\u20131756 (2018).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"9564_CR77","doi-asserted-by":"publisher","first-page":"e9759","DOI":"10.1002\/rcm.9759","volume":"38","author":"G Espadas","year":"2024","unstructured":"Espadas, G. et al. Spectral libraries from nucleobases and deoxyribonucleosides facilitate the identification of ribonucleosides by nano\u2010flow liquid chromatography\u2013tandem mass spectrometry. Rapid Commun. Mass Spectrom. 38, e9759 (2024).","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"9564_CR78","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1021\/acs.jproteome.5b00981","volume":"15","author":"C Lazar","year":"2016","unstructured":"Lazar, C., Gatto, L., Ferro, M., Bruley, C. & Burger, T. Accounting for the multiple natures of missing values in label-free quantitative proteomics data sets to compare imputation strategies. J. Proteome Res. 15, 1116\u20131125 (2016).","journal-title":"J. Proteome Res."},{"key":"9564_CR79","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cmet.2020.07.013","volume":"32","author":"S Hui","year":"2020","unstructured":"Hui, S. et al. Quantitative fluxomics of circulating metabolites. Cell Metab. 32, 676\u2013688.e4 (2020).","journal-title":"Cell Metab."},{"key":"9564_CR80","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"9564_CR81","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe0834","volume":"7","author":"MW Zimmerman","year":"2021","unstructured":"Zimmerman, M. W. et al. Retinoic acid rewires the adrenergic core regulatory circuitry of childhood neuroblastoma. Sci. Adv. 7, eabe0834 (2021).","journal-title":"Sci. Adv."},{"key":"9564_CR82","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782 (2019).","journal-title":"Nat. Biotechnol."},{"key":"9564_CR83","doi-asserted-by":"publisher","first-page":"e004807","DOI":"10.1136\/jitc-2022-004807","volume":"10","author":"A Costa","year":"2022","unstructured":"Costa, A. et al. Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma. J. Immunother. Cancer 10, e004807 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"9564_CR84","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan, E. L. & Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457\u2013481 (1958).","journal-title":"J. Am. Stat. Assoc."},{"key":"9564_CR85","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2307\/2344317","volume":"135","author":"R Peto","year":"1972","unstructured":"Peto, R. & Peto, J. Asymptotically efficient rank invariant test procedures. J. R. Stat. Soc. A 135, 185 (1972).","journal-title":"J. R. Stat. Soc. A"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09564-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09564-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09564-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T07:04:13Z","timestamp":1760598253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09564-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":85,"journal-issue":{"issue":"8085","published-print":{"date-parts":[[2025,10,16]]}},"alternative-id":["9564"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-09564-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.01.07.573662","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"30 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.D.R. is a member of the Rutgers Cancer Institute of New Jersey and the University of Pennsylvania Diabetes Research Center; a co-founder, director and stockholder in Raze Therapeutics and Farber Partners; a co-founder and stockholder in Fargo Biotechnologies; and an advisor and stockholder in Empress Therapeutics, Bantam Pharmaceuticals, Faeth Therapeutics, Colorado Research Partners and Rafael Pharmaceuticals. The University of Z\u00fcrich has filed a provisional patent on combining difluormethylornithine with amino acid manipulations for therapeutic use.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}